Clorox (NYSE:CLX) PT Lowered to $136.00

Clorox logo with Consumer Staples background

Clorox (NYSE:CLX - Free Report) had its target price reduced by Barclays from $148.00 to $136.00 in a research note issued to investors on Wednesday, Benzinga reports. Barclays currently has an underweight rating on the stock.

CLX has been the topic of a number of other research reports. Jefferies Financial Group upgraded Clorox from an underperform rating to a hold rating and set a $145.00 target price on the stock in a research report on Tuesday, March 26th. Bank of America upgraded Clorox from an underperform rating to a neutral rating and boosted their price target for the company from $120.00 to $150.00 in a research report on Friday, December 15th. JPMorgan Chase & Co. boosted their price target on Clorox from $145.00 to $152.00 and gave the company a neutral rating in a research report on Thursday, January 18th. Citigroup restated a neutral rating and issued a $165.00 price target (down previously from $170.00) on shares of Clorox in a research report on Tuesday, April 2nd. Finally, DA Davidson restated a neutral rating and issued a $162.00 price target on shares of Clorox in a research report on Monday, February 5th. Four equities research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of Hold and an average target price of $149.13.


View Our Latest Report on Clorox

Clorox Stock Up 0.2 %

NYSE CLX traded up $0.34 during trading on Wednesday, reaching $144.36. 1,014,482 shares of the company's stock were exchanged, compared to its average volume of 1,231,640. The stock has a market cap of $17.92 billion, a P/E ratio of 229.15, a price-to-earnings-growth ratio of 2.26 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. The company has a 50 day moving average price of $151.55 and a two-hundred day moving average price of $141.26. Clorox has a 1 year low of $114.68 and a 1 year high of $178.21.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.08 by $1.08. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. Clorox's revenue for the quarter was up 16.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.98 EPS. On average, equities research analysts anticipate that Clorox will post 5.51 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 3.33%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox's payout ratio is currently 761.92%.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of CLX. Tyler Stone Wealth Management acquired a new stake in shares of Clorox during the 2nd quarter worth $25,000. O Dell Group LLC acquired a new stake in shares of Clorox during the 4th quarter worth $28,000. Fortitude Family Office LLC acquired a new stake in shares of Clorox during the 4th quarter worth $29,000. Northwest Financial Advisors acquired a new stake in shares of Clorox during the 4th quarter worth $29,000. Finally, Core Wealth Advisors Inc. acquired a new stake in shares of Clorox during the 4th quarter worth $29,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Analyst Recommendations for Clorox (NYSE:CLX)

Should you invest $1,000 in Clorox right now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Featured Articles and Offers

Search Headlines: